نتایج جستجو برای: 5 fluorouracil colon cancer

تعداد نتایج: 2083830  

Journal: :Molecular cancer therapeutics 2005
Leeona Galligan Daniel B Longley Miranda McEwan Timothy R Wilson Kirsty McLaughlin Patrick G Johnston

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has recently attracted attention as a potential therapeutic agent in the treatment of cancer. We assessed the roles of p53, TRAIL receptors, and cellular Fas-associated death domain-like interleukin-1beta-converting enzyme inhibitory protein (c-FLIP) in regulating the cytotoxic effects of recombinant TRAIL (rTRAIL) alone and in com...

2015
Amy V. Paschall Kebin Liu

5-Fluorouracil (5-FU) is the standard chemotherapy for certain high risk stage 2 and all stages 3 and 4 human colorectal cancer patients. However, patients often develop chemoresistance to 5-FU. We have identified verticillin A from Verticillium-infected wild mushrooms as a potent anti-cancer agent that effectively suppresses 5-FU-resistant human colon cancer cells. Interestingly, a sublethal d...

Journal: :Molecular cancer therapeutics 2002
Saskia T C Neuteboom Patricia L Karjian Christopher R Boyer Malgorzhata Beryt Mark Pegram Geoffrey M Wahl H Michael Shepard

NB1011, a phosphoramidate derivative of (E)-5-(2-bromovinyl)-2'-deoxyuridine, is a novel small molecule anticancer agent. NB1011 is selectively active against tumor cells expressing high levels of thymidylate synthase (TS), a critical enzyme in DNA biosynthesis. NB1011 is different from the current TS-targeted drugs, which require inhibition of TS to be effective, because NB1011 cytotoxicity de...

Journal: :Cancer research 2010
Anne-Frédérique Dessein Laurence Stechly Nicolas Jonckheere Patrick Dumont Didier Monté Emmanuelle Leteurtre Stéphanie Truant François-René Pruvot Martin Figeac Mohamed Hebbar Charles-Henri Lecellier Thécla Lesuffleur Rodrigue Dessein Georges Grard Marie-José Dejonghe Yvan de Launoit Yasuhiro Furuichi Grégoire Prévost Nicole Porchet Christian Gespach Guillemette Huet

Metastasis and drug resistance are major problems in cancer chemotherapy. The purpose of this work was to analyze the molecular mechanisms underlying the invasive potential of drug-resistant colon carcinoma cells. Cellular models included the parental HT-29 cell line and its drug-resistant derivatives selected after chronic treatment with either 5-fluorouracil, methotrexate, doxorubicin, or oxa...

Journal: :Anticancer research 2009
Shoujiro Torigoe Yutaka Ogata Keiko Matono Kazuo Shirouzu

BACKGROUND The aim of this study was to clarify the molecular mechanisms of the sequence-dependent antitumor activity of SN-38 and 5-fluorouracil (5-FU) against colon cancer cells. MATERIALS AND METHODS KM12SM and HCT116 colon cancer cells were exposed to 5-FU and/or SN-38 in various conditions. The nature of interactions was determined by median-effect analysis. Cell cycle, apoptosis, and ex...

2015
DONG ZHOU YI ZHANG DAOMING LIANG YONG YUAN DEMIAO ZENG JIAYONG CHEN JIE YANG

The aim of this study was to investigate the effects of small interfering RNA (siRNA) targeting human growth hormone receptor (hGHR) combined with 5-fluorouracil (5-FU) on the hepatic metastasis of colon cancer. The animal model of liver metastases using human SW480 colon cancer cells was established on BALB/c mice and the siRNA interfering plasmid targeting hGHR gene was constructed. The tumor...

2014
Pratima Nangia-Makker Yingjie Yu Anita Vasudevan Lulu Farhana Sindhu G. Rajendra Edi Levi Adhip P. N. Majumdar

Accumulating evidence suggests that metformin, a biguanide class of anti-diabetic drugs, possesses anti-cancer properties. However, most of the studies to evaluate therapeutic efficacy of metformin have been on primary cancer. No information is available whether metformin could be effectively used for recurrent cancer, specifically colorectal cancer (CRC) that affects up to 50% of patients trea...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید